Its mediation of the S1P/S1PR2 axis further facilitates epithelial-mesenchymal transition (EMT) and chemotherapy resistance, and it can also exacerbate immune suppression in the tumor microenvironment by regulating the NF-κB inflammatory pathway. The gene discussed is NFKB1; the disease is neoplasm.